Combined laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal mesothelioma.
The role of minimally invasive, laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) has been reported by several centers around the world, mainly to palliate intractable ascites in patients with extensive peritoneal surface malignancies who are not candidates for a complete cytoreduction. In this paper, we report on the first case of combined laparoscopic cytoreductive surgery and HIPEC with curative intent in a patient with limited peritoneal mesothelioma.
Esquivel
Jesus
J
Department of Surgical Oncology, St. Agnes Hospital, 900 Caton Avenue, Baltimore, MD 21229, USA. jesusesquivel@yahoo.com
Averbach
Andrew
A
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007263:Infusions, Parenteral; D010535:Laparoscopy; D008654:Mesothelioma / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D010534:Peritoneal Neoplasms / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents; D004317:Doxorubicin; D002945:Cisplatin